{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:43:41Z","timestamp":1773265421867,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/QUI\/50006\/2013"],"award-info":[{"award-number":["UID\/QUI\/50006\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Liquids"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.molliq.2017.02.027","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T20:17:04Z","timestamp":1486671424000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Anti-inflammatory choline based ionic liquids: Insights into their lipophilicity, solubility and toxicity parameters"],"prefix":"10.1016","volume":"232","author":[{"given":"Ana M.O.","family":"Azevedo","sequence":"first","affiliation":[]},{"given":"Susana P.F.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Ana F.V.","family":"Dias","sequence":"additional","affiliation":[]},{"given":"Alexandre H.O.","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Paula C.A.G.","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Katharina","family":"Bica","sequence":"additional","affiliation":[]},{"given":"Anna K.","family":"Ressmann","sequence":"additional","affiliation":[]},{"given":"Marieta L.C.","family":"Passos","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9 R.T.S.","family":"Ara\u00fajo","sequence":"additional","affiliation":[]},{"given":"Salette","family":"Reis","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6539-1741","authenticated-orcid":false,"given":"M. L\u00facia M.F.S.","family":"Saraiva","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.molliq.2017.02.027_bb0005","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.embor.embor748","article-title":"The big and small of drug discovery\u2014biotech versus pharma: advantages and drawbacks in drug development","volume":"4","author":"Moore","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molliq.2017.02.027_bb0010","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/aic.11555","article-title":"From form to function: crystallization of active pharmaceutical ingredients","volume":"54","author":"Variankaval","year":"2008","journal-title":"AIChE J"},{"key":"10.1016\/j.molliq.2017.02.027_bb0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1367-5931(03)00055-3","article-title":"Profiling drug-like properties in discovery research","volume":"7","author":"Di","year":"2003","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.molliq.2017.02.027_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1039\/B711717E","article-title":"Green chemistry tools to influence a medicinal chemistry and research chemistry based organisation","volume":"10","author":"Alfonsi","year":"2008","journal-title":"Green Chem."},{"key":"10.1016\/j.molliq.2017.02.027_bb0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11095-009-0030-0","article-title":"Crystalline vs. ionic liquid salt forms of active pharmaceutical ingredients: a position paper","volume":"27","author":"Stoimenovski","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.molliq.2017.02.027_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrd3439","article-title":"Phase II failures: 2008\u20132010","volume":"10","author":"Arrowsmith","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molliq.2017.02.027_bb0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijpharm.2012.11.028","article-title":"Use of pharmaceutical salts and cocrystals to address the issue of poor solubility","volume":"453","author":"Elder","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.molliq.2017.02.027_bb0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev-chembioeng-060713-040024","article-title":"Ionic liquids in pharmaceutical applications","volume":"5","author":"Marrucho","year":"2014","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/j.molliq.2017.02.027_bb0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/157019312800604698","article-title":"Ionic liquids: a new strategy in pharmaceutical synthesis","volume":"9","author":"Siodmiak","year":"2012","journal-title":"Mini-Rev. Org. Chem."},{"key":"10.1016\/j.molliq.2017.02.027_bb0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijpharm.2012.12.030","article-title":"Imidazolium ionic liquids as solvents of pharmaceuticals: influence on HSA binding and partition coefficient of nimesulide","volume":"443","author":"Azevedo","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.molliq.2017.02.027_bb0055","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ijpharm.2012.10.035","article-title":"Ionic liquids as ingredients in topical drug delivery systems","volume":"441","author":"Dobler","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.molliq.2017.02.027_bb0060","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1039\/C3CC48650H","article-title":"Ionic liquids provide unique opportunities for oral drug delivery: structure optimization and in vivo evidence of utility","volume":"50","author":"Williams","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.molliq.2017.02.027_bb0065","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/cmdc.201100082","article-title":"Ionic liquids as active pharmaceutical ingredients","volume":"6","author":"Ferraz","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.molliq.2017.02.027_bb0070","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1039\/c2md00269h","article-title":"Development of novel ionic liquids based on ampicillin","volume":"3","author":"Ferraz","year":"2012","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.molliq.2017.02.027_bb0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1039\/B813213P","article-title":"Ionic liquids with dual biological function: sweet and anti-microbial, hydrophobic quaternary ammonium-based salts","volume":"33","author":"Hough-Troutman","year":"2009","journal-title":"New J. Chem."},{"key":"10.1016\/j.molliq.2017.02.027_bb0080","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1039\/c3nj00731f","article-title":"Active pharmaceutical ingredients based on salicylate ionic liquids: insights into the evaluation of pharmaceutical profiles","volume":"37","author":"Pinto","year":"2013","journal-title":"New J. Chem."},{"key":"10.1016\/j.molliq.2017.02.027_bb0085","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1039\/b923855g","article-title":"In search of pure liquid salt forms of aspirin: ionic liquid approaches with acetylsalicylic acid and salicylic acid","volume":"12","author":"Bica","year":"2010","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.molliq.2017.02.027_bb0090","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1039\/b706677p","article-title":"The third evolution of ionic liquids: active pharmaceutical ingredients","volume":"31","author":"Hough","year":"2007","journal-title":"New J. Chem."},{"key":"10.1016\/j.molliq.2017.02.027_bb0095","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1039\/b925147b","article-title":"Confused ionic liquid ions-a \u201cliquification\u201d and dosage strategy for pharmaceutically active salts","volume":"46","author":"Bica","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.molliq.2017.02.027_bb0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejpb.2015.05.027","article-title":"'Pro et contra' ionic liquid drugs\u2014challenges and opportunities for pharmaceutical translation","volume":"94","author":"Balk","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.molliq.2017.02.027_bb0105","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/cg8009496","article-title":"Exploring an anti-crystal engineering approach to the preparation of pharmaceutically active ionic liquids","volume":"9","author":"Dean","year":"2009","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.molliq.2017.02.027_bb0110","doi-asserted-by":"crossref","first-page":"28126","DOI":"10.1039\/C3RA47615D","article-title":"Cholinium-based ionic liquids with pharmaceutically active anions","volume":"4","author":"Araujo","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.molliq.2017.02.027_bb0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhazmat.2013.11.052","article-title":"Automated evaluation of pharmaceutically active ionic liquids' (eco)toxicity through the inhibition of human carboxylesterase and Vibrio fischeri","volume":"265","author":"Costa","year":"2014","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.molliq.2017.02.027_bb0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2014.04.034","article-title":"Novel organic salts based on fluoroquinolone drugs: synthesis, bioavailability and toxicological profiles","volume":"469","author":"Florindo","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.molliq.2017.02.027_bb0125","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.jpain.2013.01.624","article-title":"A phase I, randomized, open-label, cross-over study of the pharmacokinetics, dermal tolerability, and safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in healthy volunteers","volume":"14","author":"Miwa","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.molliq.2017.02.027_bb0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.talanta.2015.12.009","article-title":"Automated evaluation of protein binding affinity of anti-inflammatory choline based ionic liquids","volume":"150","author":"Ribeiro","year":"2016","journal-title":"Talanta"},{"key":"10.1016\/j.molliq.2017.02.027_bb0135","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00296-011-2263-6","article-title":"A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity","volume":"32","author":"Conaghan","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.molliq.2017.02.027_bb0140","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1753-4887.2009.00246.x","article-title":"Choline: an essential nutrient for public health","volume":"67","author":"Zeisel","year":"2009","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.molliq.2017.02.027_bb0145","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1002\/jps.21244","article-title":"Alternative measures of lipophilicity: from octanol-water partitioning to IAM retention","volume":"97","author":"Giaginis","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.molliq.2017.02.027_bb0150","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.plipres.2013.08.003","article-title":"Interaction of nonsteroidal anti-inflammatory drugs with membranes: in vitro assessment and relevance for their biological actions","volume":"52","author":"Pereira-Leite","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.molliq.2017.02.027_bb0155","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chemphyslip.2010.07.004","article-title":"Effects of resveratrol on membrane biophysical properties: relevance for its pharmacological effects","volume":"163","author":"Brittes","year":"2010","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.molliq.2017.02.027_bb0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00216-003-2089-5","article-title":"Partition and location of nimesulide in EPC liposomes: a spectrophotometric and fluorescence study","volume":"377","author":"Ferreira","year":"2003","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.molliq.2017.02.027_bb0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0928-4931(01)00372-1","article-title":"Interaction of drugs with hexadecylphosphocholine micelles. Derivative spectroscopy, acid-base and solubility studies","volume":"18","author":"de Castro","year":"2001","journal-title":"Mater. Sci. Eng. C Biomim. Supramol. Syst."},{"key":"10.1016\/j.molliq.2017.02.027_bb0170","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/nprot.2010.137","article-title":"High-throughput microplate assay for the determination of drug partition coefficients","volume":"5","author":"Magalhaes","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.molliq.2017.02.027_bb0175","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1002\/jps.23233","article-title":"Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen","volume":"101","author":"Shohin","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.molliq.2017.02.027_bb0180","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.supflu.2010.09.023","article-title":"Formation of submicron poorly water-soluble drugs by rapid expansion of supercritical solution (RESS): results for naproxen","volume":"55","author":"Turk","year":"2010","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.molliq.2017.02.027_bb0185","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.chemosphere.2010.11.046","article-title":"Automated evaluation of the effect of ionic liquids on catalase activity","volume":"82","author":"Pinto","year":"2011","journal-title":"Chemosphere"},{"key":"10.1016\/j.molliq.2017.02.027_bb0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ecoenv.2012.02.013","article-title":"Automated high-throughput Vibrio fischeri assay for (eco)toxicity screening: application to ionic liquids","volume":"80","author":"Pinto","year":"2012","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.molliq.2017.02.027_bb0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jhazmat.2016.02.005","article-title":"Automated cytochrome c oxidase bioassay developed for ionic liquids' toxicity assessment","volume":"309","author":"Costa","year":"2016","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.molliq.2017.02.027_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.microc.2012.05.012","article-title":"Recent applications in derivative ultraviolet\/visible absorption spectrophotometry: 2009\u20132011: a review","volume":"106","author":"Bosch Ojeda","year":"2013","journal-title":"Microchem. J."},{"key":"10.1016\/j.molliq.2017.02.027_bb0205","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1021\/la201914h","article-title":"Bioinspired choline-like ionic liquids: their penetration ability through cell membranes and application to SEM visualization of hydrous samples","volume":"27","author":"Kawai","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.molliq.2017.02.027_bb0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jpba.2007.10.030","article-title":"Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound","volume":"46","author":"Baka","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.molliq.2017.02.027_bb0215","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.addr.2007.05.010","article-title":"Salt formation to improve drug solubility","volume":"59","author":"Serajuddin","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.molliq.2017.02.027_bb0220","series-title":"On the Preparation and Characterization of Water-soluble Choline Salts of Carboxylic Acid Drugs","author":"Murti","year":"1993"},{"key":"10.1016\/j.molliq.2017.02.027_bb0225","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijpharm.2013.08.010","article-title":"Evaluation of solubility and partition properties of ampicillin-based ionic liquids","volume":"456","author":"Florindo","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.molliq.2017.02.027_bb0230","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12257-009-3079-z","article-title":"Toward advanced ionic liquids. Polar, enzyme-friendly solvents for biocatalysis","volume":"15","author":"Gorke","year":"2010","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"10.1016\/j.molliq.2017.02.027_bb0235","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1039\/c2gc35890e","article-title":"Design of environmentally friendly ionic liquid aqueous two-phase systems for the efficient and high activity extraction of proteins","volume":"14","author":"Li","year":"2012","journal-title":"Green Chem."},{"key":"10.1016\/j.molliq.2017.02.027_bb0240","article-title":"Evaluation of toxicity and biodegradability of cholinium amino acids ionic liquids","volume":"8","author":"Hou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molliq.2017.02.027_bb0245","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1039\/b918726j","article-title":"Cyto-toxicity and biocompatibility of a family of choline phosphate ionic liquids designed for pharmaceutical applications","volume":"12","author":"Weaver","year":"2010","journal-title":"Green Chem."},{"key":"10.1016\/j.molliq.2017.02.027_bb0250","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.bbamem.2013.03.017","article-title":"Interaction of choline salts with artificial biological membranes: DSC studies elucidating cellular interactions","volume":"1828","author":"Weaver","year":"2013","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.molliq.2017.02.027_bb0255","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0021-9673(01)01154-2","article-title":"Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri","volume":"938","author":"Farre","year":"2001","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.molliq.2017.02.027_bb0260","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ecoenv.2014.01.003","article-title":"Ecotoxicity analysis of cholinium-based ionic liquids to Vibrio fischeri marine bacteria","volume":"102","author":"Ventura","year":"2014","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.molliq.2017.02.027_bb0265","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1039\/C5GC01129A","article-title":"Environmental safety of cholinium-based ionic liquids: assessing structure-ecotoxicity relationships","volume":"17","author":"Santos","year":"2015","journal-title":"Green Chem."},{"key":"10.1016\/j.molliq.2017.02.027_bb0270","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s10541-005-0091-6","article-title":"Zinc ions as cytochrome c oxidase inhibitors: two sites of action","volume":"70","author":"Kuznetsova","year":"2005","journal-title":"Biochem. Mosc."},{"key":"10.1016\/j.molliq.2017.02.027_bb0275","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbabio.2008.03.021","article-title":"A dynamic model of nitric oxide inhibition of mitochondrial cytochrome c oxidase","volume":"1777","author":"Cooper","year":"2008","journal-title":"Biochim. Biophys. Acta Bioenerg."}],"container-title":["Journal of Molecular Liquids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167732216331270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167732216331270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T12:21:48Z","timestamp":1655641308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167732216331270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":55,"alternative-id":["S0167732216331270"],"URL":"https:\/\/doi.org\/10.1016\/j.molliq.2017.02.027","relation":{},"ISSN":["0167-7322"],"issn-type":[{"value":"0167-7322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory choline based ionic liquids: Insights into their lipophilicity, solubility and toxicity parameters","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Liquids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molliq.2017.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}